These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8991943)

  • 1. Nucleotide sequence variation in the hypervariable region of the hepatitis C virus in the sera of chronic hepatitis C patients undergoing controlled interferon-alpha therapy.
    Yeh BI; Han KH; Oh SH; Kim HS; Hong SH; Oh SH; Kim YS
    J Med Virol; 1996 Jun; 49(2):95-102. PubMed ID: 8991943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa.
    Zeuzem S; Lee JH; Roth WK
    Hepatology; 1997 Mar; 25(3):740-4. PubMed ID: 9049228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome.
    Aiyama T; Yoshioka K; Okumura A; Takayanagi M; Iwata K; Ishikawa T; Kakumu S
    Hepatology; 1996 Dec; 24(6):1346-50. PubMed ID: 8938159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide sequence variations in the internal ribosome entry site of hepatitis C virus-1b: no association with efficacy of interferon therapy or serum HCV-RNA levels.
    Yamamoto C; Enomoto N; Kurosaki M; Yu SH; Tazawa J; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Dec; 26(6):1616-20. PubMed ID: 9398006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy.
    Shindo M; Hamada K; Koya S; Arai K; Sokawa Y; Okuno T
    Hepatology; 1996 Nov; 24(5):1018-23. PubMed ID: 8903369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic complexity of the hypervariable region 1 (HVR1) of hepatitis C virus (HCV): influence on the characteristics of the infection and responses to interferon alfa therapy in patients with chronic hepatitis C.
    Pawlotsky JM; Pellerin M; Bouvier M; Roudot-Thoraval F; Germanidis G; Bastie A; Darthuy F; Rémiré J; Soussy CJ; Dhumeaux D
    J Med Virol; 1998 Apr; 54(4):256-64. PubMed ID: 9557291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence variations of the hypervariable region of hepatitis C virus and their clinical significance.
    Zhang S; Wang W; Zhou K; Liu H
    Chin Med J (Engl); 2000 Dec; 113(12):1075-9. PubMed ID: 11776139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection.
    Chayama K; Tsubota A; Kobayashi M; Okamoto K; Hashimoto M; Miyano Y; Koike H; Kobayashi M; Koida I; Arase Y; Saitoh S; Suzuki Y; Murashima N; Ikeda K; Kumada H
    Hepatology; 1997 Mar; 25(3):745-9. PubMed ID: 9049229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection.
    Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M
    Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus.
    Kato T; Mizokami M; Nakano T; Orito E; Ohba K; Kondo Y; Tanaka Y; Ueda R; Mukaide M; Fujita K; Yasuda K; Iino S
    J Med Virol; 1998 Jun; 55(2):109-17. PubMed ID: 9598930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients.
    Booth JC; Kumar U; Webster D; Monjardino J; Thomas HC
    Hepatology; 1998 Jan; 27(1):223-7. PubMed ID: 9425941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-beta therapy.
    Kurosaki M; Enomoto N; Murakami T; Sakuma I; Asahina Y; Yamamoto C; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C
    Hepatology; 1997 Mar; 25(3):750-3. PubMed ID: 9049230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
    Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon sensitivity-determining region of nonstructural region 5A of hepatitis C virus genotype 1b correlates with serum alanine aminotransferase levels in chronic infection.
    Yoshioka K; Ito H; Watanabe K; Yano M; Ishigami M; Mizutani T; Sasaki Y; Goto H
    J Viral Hepat; 2005 Mar; 12(2):139-45. PubMed ID: 15720528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
    Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
    Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients.
    Kanazawa Y; Hayashi N; Mita E; Li T; Hagiwara H; Kasahara A; Fusamoto H; Kamada T
    Hepatology; 1994 Nov; 20(5):1121-30. PubMed ID: 7523271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
    Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
    Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of hepatitis C: patients with normal aminotransferase levels.
    Marcellin P; Lévy S; Erlinger S
    Hepatology; 1997 Sep; 26(3 Suppl 1):133S-136S. PubMed ID: 9305678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.